|Total RNA Purification Kit 96-Well Kit||24300||2 plates|
Total RNA Purification 96-Well Kit
This 96-well kit provides a rapid method for the high-throughput isolation and purification of total RNA in 30 minutes using vacuum manifold, plate centrifuge or liquid handlers with vacuum capabilities. Total RNA can be isolated from a broad range of sample sources including cultured cells, tissues, blood, serum, plasma, bacteria, yeast, fungi, and viruses.
The eluted RNA is consistent from well-to-well with high quality and purity, with excellent RIN values and A260/A280, and is suitable for downstream applications including qRT-PCR, RT-PCR, microarrays, NGS and more.
The kit purifies all sizes of RNA from large mRNA, lncRNA down to microRNA (miRNA) in the same fraction without the requirement of phenol. Isolate all RNA sequences at an equal rate irrespective of size. Moreover, when the RNA sequences are small (e.g. miRNA), the column binds small RNAs regardless of their GC content.
Binding Capacity Per Well
Maximum Loading Volume Per Well
|Size of RNA Purified||
All sizes, including < 200 nt
|Time to Complete 96 Purifications||
HeLa Cells (1 x 106 Cells)
E. coli (1 x 109 cells)
Brain (10 mg)
Liver (10 mg)
Blood (50 μL, Hamster)
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. These reagents should remain stable for at least 1 year in their unopened containers.
|Title||Effects of crude oil exposure and elevated temperature on the liver transcriptome of polar cod (Boreogadus saida)|
|Journal||Aquatic Toxicology. 2015.|
|Authors||Øivind Andersen, Marianne Frantzen, Marte Rosland, Gerrit Timmerhaus, Adrijana Skugor, Aleksei Krasnov|
|Title||Fission yeast Cactin restricts telomere transcription and elongation by controlling Rap1 levels.|
|Journal||The EMBO Journal. 2014.|
|Authors||Luca E Lorenzi, Amadou Bah1, Harry Wischnewski, Vadim Shchepachev, Charlotte Soneson, Marco Santagostino and Claus M Azzalin.|
|Title||RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model.|
|Journal||PLOS One. 2014.|
|Authors||Praful Aggarwal, Amy Turner, Andrea Matter, Steven J. Kattman, Alexander Stoddard, Rachel Lorier, Bradley J. Swanson, Donna K. Arnett, Ulrich Broeckel.|
|Title||Evaluation of infectious titer in a candidate HSV type 2 vaccine by a quantitative molecular approach.|
|Journal||BMC Microbiology. 2013.|
|Authors||Azizi A, Tang M, Gisonni-Lex L, Mallet L.|
Copyright © 2015 - Norgen Biotek Corp.